Drug Development

U.S. SBIR grant awarded for manufacturing antibodies in transgenic plants

Published in Cancer Weekly, August 16th, 2005

Altor BioScience Corporation announced that it has received a phase I Small Business Innovation Research (SBIR) grant from the National Cancer Institute (NCI) to support development of its proprietary processes for making therapeutic antibodies in transgenic lettuce.

The grant application was submitted in response to president Bush's Executive Order encouraging innovation in manufacturing-related research and development. Altor's long-term goal in this project is to use its plant expression system to produce a variety of immunotherapeutic drugs at very low manufacturing costs.

Valentin Negrouk, PhD, senior scientist and principal investigator of the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2005-08-16)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry